YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 13497-13512
DOI: 10.1007/s00210-026-05146-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 27.03.2026. Verfasst von Yuan Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwai Zheng Street, Donghu District, N…. Hauptthemen laut MEDLINE: Paclitaxel, Triple Negative Breast Neoplasms, Y-Box-Binding Protein 1, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The National Nature Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwai Zheng Street, Donghu District, Nanchang, 330000, China.
- Department of Lymphohematology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, 330029, China.
- Department of Breast Surgery, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, 330029, China.
- Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwai Zheng Street, Donghu District, Nanchang, 330000, China. ndzhlyy1394@ncu.edu.cn.
Förderung
- The National Nature Science Foundation of China
Zitieren
APA
Cao, Y., Peng, Z., Yu, T., & Dong, H. (2026). YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 13497-13512. https://doi.org/10.1007/s00210-026-05146-7
Vancouver
Cao Y, Peng Z, Yu T, Dong H. YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):13497-13512. doi:10.1007/s00210-026-05146-7
BibTeX
@article{Cao2026,
author = {Cao, Yuan and Peng, Zhiqiang and Yu, Tenghua and Dong, Hanzhi},
title = {YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {13497--13512},
doi = {10.1007/s00210-026-05146-7}
}
EUVIMED